Bismuth Nanoparticle and Polyhydroxybutyrate Coatings Enhance the Radiopacity of Absorbable Inferior Vena Cava Filters for Fluoroscopy-Guided Placement and Longitudinal Computed Tomography Monitoring in Pigs.
Jossana A DamascoSteven Y HuangJoy Vanessa D PerezJohn Andrew T ManongdoKatherine A DixonMalea L WilliamsMegan C JacobsenRoland BarbosaGino Martin CanlasGouthami ChintalapaniAdam D MelanconRick R LaymanNatalie W FowlkesElizabeth M WhitleyMarites P MelanconPublished in: ACS biomaterials science & engineering (2022)
Inferior vena cava filters (IVCFs) constructed with poly- p -dioxanone (PPDO) are promising alternatives to metallic filters and their associated risks and complications. Incorporating high-Z nanoparticles (NPs) improves PPDO IVCFs' radiopacity without adversely affecting their safety or performance. However, increased radiopacity from these studies are insufficient for filter visualization during fluoroscopy-guided PPDO IVCF deployment. This study focuses on the use of bismuth nanoparticles (BiNPs) as radiopacifiers to render sufficient signal intensity for the fluoroscopy-guided deployment and long-term CT monitoring of PPDO IVCFs. The use of polyhydroxybutyate (PHB) as an additional layer to increase the surface adsorption of NPs resulted in a 2-fold increase in BiNP coating (BiNP-PPDO IVCFs, 3.8%; BiNP-PPDO + PHB IVCFs, 6.2%), enabling complete filter visualization during fluoroscopy-guided IVCF deployment and, 1 week later, clot deployment. The biocompatibility, clot-trapping efficacy, and mechanical strength of the control PPDO (load-at-break, 6.23 ± 0.13 kg), BiNP-PPDO (6.10 ± 0.09 kg), and BiNP-PPDO + PHB (6.15 ± 0.13 kg) IVCFs did not differ significantly over a 12-week monitoring period in pigs. These results indicate that BiNP-PPDO + PHB can increase the radiodensity of a novel absorbable IVCF without compromising device strength. Visualizing the device under conventional radiographic imaging is key to allow safe and effective clinical translation of the device.
Keyphrases
- inferior vena cava
- computed tomography
- pulmonary embolism
- vena cava
- positron emission tomography
- oxide nanoparticles
- high resolution
- catheter ablation
- magnetic resonance imaging
- image quality
- contrast enhanced
- dual energy
- magnetic resonance
- randomized controlled trial
- clinical trial
- ultrasound guided
- human health
- risk assessment
- single molecule
- placebo controlled